Gc. Viscomi et al., Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies, J INTERF CY, 19(4), 1999, pp. 319-326
To gain more insight into similarities of different interferon-alpha (IFN-a
lpha) species, we evaluated neutralization and immunoactivity of a variety
of IFN preparations with various monoclonal antibodies (IFN-alpha mAb), Nin
e IFN-alpha mAb obtained through immunization with recombinant IFN-alpha (r
mAb), lymphoblastoid IFN-alpha (LY mAb), and leukocyte IFN-alpha (LE mAb) w
ere tested. The IFN-alpha mAb were evaluated for their ability to neutraliz
e the antiviral activity of 11 recombinant IFN-alpha subtypes, two recombin
ant IFN-alpha hybrids, and lymphoblastoid and leukocyte IFN-alpha preparati
ons. The same IFN-alpha mAb were also used in immunoblotting, and some of t
hem were used in immunoaffinity chromatography. The results of the neutrali
zation assay reveal that the IFN-alpha mAb significantly differ in their ab
ility to neutralize the individual IFN-alpha species. Interestingly, none o
f the IFN-alpha mAb was able to neutralize all the IFN-cu species, In parti
cular, rmAb were unable to neutralize LE-IFN-alpha or LY-IFN-alpha, whereas
LE mAb and LY mAb efficiently neutralized rIFN-alpha 2. In some cases, the
epitopes to which IFN-alpha mAb are directed were identified through the u
se of synthetic fragments of IFN-alpha 2 or by evaluating the selectivity i
n binding to IFN-alpha subtypes.